BioAspect

BioAspect is dedicated to providing high quality research tools and contract research services to Life Scientists.

[BioAspect @BioAspect]

January New Product Alert: GLYCININ AND β-CONGLYCININ ELISA KITS and
HUMAN GELSOLIN RECOMBINANT PROTEIN. https://t.co/9752VUhrOG

[BioAspect @BioAspect]

Amazing news - monkeys have been cloned using Dolly the sheep technique! Wondering who is next?
https://t.co/tNYqab3WvP

[BioAspect @BioAspect]

New product alert from our supplier Biomiga: https://t.co/oWySSN7rNG
First and only mini-prep kit in the world for purifying high quality plasmid DNA from up to 2 mL of cell culture. Fast - 10 min protocol; high purity and yield, no chaotropic salts,

[BioAspect @BioAspect]

Scientists just added two functional letters to the genetic code. https://t.co/4E65fUs2Nb

[BioAspect @BioAspect]

This is the first report of an intervention significantly reducing dementia risk. Cognitive training called “speed of processing” significantly reduced the risk of dementia in older adults followed up to 10 years. https://t.co/WibgsQcx5P

[BioAspect @BioAspect]

Amazing! Drug delivery with the flip of a light switch. Turn it on, turn it off — a new antibiotic responds to visible light. https://t.co/SAvdNgR5Xg

[BioAspect @BioAspect]

Don't miss our FALL PROMOTIONS!!! Click for details: https://t.co/HHnyA3uTUt

[BioAspect @BioAspect]

ZIKA VIRUS AS A TREATMENT OF HARDEST-TO-TREAT CANCERS? A NEW HOPE FOR GLYOBLASTOMA PATIENTS. https://t.co/QNExjZKXl8

[BioAspect @BioAspect]

ATTENTION!!! FREE RNA/DNA KITS FROM OUR NEW SUPPLIER BIOMIGA:
https://t.co/gWIQX85jGi. REQUEST YOUR KIT TODAY AND TRY FOR FREE!

[BioAspect @BioAspect]

TRIAL SIZE ELISA KITS AND ANTIBODIES AVAILABLE NOW!!! REQUEST TODAY AND TEST BEFORE PAYING FULL PRICE! https://t.co/g5CIWGZNwx;

[BioAspect @BioAspect]

Using antibodies for autophagy signalling pathway in your research? They are on promotion right now, check here: https://t.co/H9MysDLu27

[BioAspect @BioAspect]

Autophagy Signalling Pathway Antibodies Promo - https://t.co/eI8ztdyUHm

[BioAspect @BioAspect]

Read how immunotherapy using recombinant antibodies help cancer patients.
https://t.co/keWBnvzfW6

[BioAspect @BioAspect]

Do you know why all antibody users should use recombinant antibodies for research? To save time and money. https://t.co/TFF8aspiMd.

[LabTube @LabTube]

The Fruit Fly as a Therapeutic Drug Screening Platform https://t.co/2jrNAMO8qn @BioAspect

[BioAspect @BioAspect]

Analysis has shown that tiny magnetic particles from air pollution in human brains may be linked to AD https://t.co/e9GVvXZTKI #science

[BioAspect @BioAspect]

Medical Xpress: Mouse study reveals genes essential for life and provides insights into human disease https://t.co/JvwdpFPjqM

[Tebubio @tebubio]

#EESActin: lunch time! Christian and Ingrid are pleased to meet you at the @tebubio booth!

[Gi Silvestre @gihchemistry]

@BlogsUnicamp Feed your brain #chemistry #acetylcholine #twitciencia
https://t.co/7Fqolkl8vn

[BioAspect @BioAspect]

Use our Drosophila therapeutic drug screening platform in your next drug discovery project #drugdiscovery #biotech